These findings have made the concept of targeting both GRPR and PSMA with a single radiotracer attractive as it can cover the whole spectrum of prostate cancer and improve the imaging sensitivity towards prostate cancers. This evidence concerns the gene FOLH1 and Familial prostate cancer.